中文
|
English
Home
|
Help
|
Contact
Return
Ibrutinib combined with gemcitabine-vinorelbine for primary refractory non-Hodgkin lymphoma
10.5045/br.2023.2023182
Author:
Muruvvet Seda AYDIN
1
; Esra CENGIZ ; Ferda CAN ; Simten DAGDAS ; Imdat DILEK ; Gulsum OZET
Author Information
1. Department of Hematology and Bone Marrow Transplantation, Ankara Bilkent City Hospital, Ankara, Turkiye
Publication Type:
Letter to the Editor
From:
Blood Research 2023;58(4):234-237
Country
Republic of Korea
Language:
English